Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06106360 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Final enrollment: 53 participants (planned 100)
    • Study completion pushed from Jun 26, 2026 to Dec 26, 2026
    • Eligibility criteria expanded, about 9 words
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Study completion date: Dec 26, 2025 to Jun 26, 2026v6
  3. Primary completion date: Jun 26, 2025 to Nov 1, 2025
    • Study completion date: Nov 26, 2025 to Dec 26, 2025
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary completion date: Jan 26, 2024 to Jun 26, 2025
    • Study completion date: Oct 26, 2024 to Nov 26, 2025
    v3
  6. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Primary endpoint revised
    • Primary completion date: Jan 31, 2024 to Jan 26, 2024
    • Study completion date: Oct 20, 2024 to Oct 26, 2024
    • Start date changed from estimate of Oct 31, 2023 to Oct 26, 2023
    • Site details revised
    • Publications: 3 to 4
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.
Trial Details
NCT Number NCT06106360
Lead Sponsor Inova Health Care Services
Conditions
(from sponsor)		 Solid Tumor, Hematological Malignancy
Related terms Hematologic Neoplasms
Enrollment 53 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov